Brazil Over-the-Counter CGM Market Industry Trends and Forecast to 2034: Segmented by (Product, User, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Brazil · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$4.9 MnPlaceholder estimate
Estimate 2025$6.7 Mn2.4% of the global market
Projected 2034$106.0 Mn 1,491.7%Adds $99.3 Mn over 9 forecast years
CAGR 2025–203436.0%Faster than 100% of 193 Medical Devices markets here
Key players5
Brazil is 2.44% of the global market.
In Latin America, the largest is Brazil (this report) at $6.7 Mn.
Fastest growing: Brazil (this report) at 36% a year.
Brazil ranks 1st of 3 by size in Latin America.
Market size projection
Brazil
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$99.3 Mn total, 2026–2034
Year-by-year market size, 2024–2034
Over-the-Counter CGM Market market size by year, Brazil
Year
Market size
Change that year
Since 2025
2024 (estimate)
$4.9 Mn
—
—
2025 (base)
$6.7 Mn
+$1.8 Mn
—
2026 (forecast)
$9.1 Mn
+$2.4 Mn
+36%
2027 (forecast)
$12.3 Mn
+$3.3 Mn
+85%
2028 (forecast)
$16.7 Mn
+$4.4 Mn
+151.5%
2029 (forecast)
$22.8 Mn
+$6.0 Mn
+242.1%
2030 (forecast)
$31.0 Mn
+$8.2 Mn
+365.3%
2031 (forecast)
$42.1 Mn
+$11.2 Mn
+532.8%
2032 (forecast)
$57.3 Mn
+$15.2 Mn
+760.5%
2033 (forecast)
$77.9 Mn
+$20.6 Mn
+1,070.3%
2034 (forecast)
$106.0 Mn
+$28.1 Mn
+1,491.7%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Brazil Over-the-Counter CGM Market Analysis Executive Summary
Over-the-counter continuous glucose monitors are sensors sold without a prescription to adults who want to see how food and activity affect their blood sugar.
Key segments of the over-the-Counter CGM market include product (Biosensors and Mobile Apps and Subscriptions) and user (Non-Insulin Type 2 Diabetes, Prediabetes and Wellness Users).
Brazil Over-the-Counter CGM market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Brazil Over-the-Counter CGM Market Dynamics
Market Growth Drivers
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the over-the-Counter CGM market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Opportunity
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the over-the-Counter CGM market, especially in fast-growing emerging economies.
Market Restraints
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the over-the-Counter CGM market. Long-term safety data and lifestyle support are still needed for many patients.
Competitive Landscape for Over-the-Counter CGM Market in Brazil
The over-the-Counter CGM market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Over-the-Counter CGM Market in Brazil
Over-the-Counter CGM in Brazil: rules, payment and health figures
Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class.[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.[2] Diabetes (adults): 12.9% of adults in 2022, the latest WHO figure for Brazil.[3]
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how over-the-Counter CGM products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Brazil.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By User
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Dexcom
7.2 Abbott Laboratories
7.3 Levels Health
7.4 Nutrisense
7.5 Signos
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The over-the-Counter CGM market can be segmented based on various criteria, including product, user and end user. Here's a breakdown of the market segmentation
Diabetes (adults, WHO): 12.9% of adults (2022). World: 14.1% of adults (2022). 4th highest of the 7 countries we cover in Latin America.[1]
Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 7 countries we cover in Latin America.[2]
Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 7 countries we cover in Latin America.[3]
How big is the Over-the-Counter CGM market in Brazil?
Placeholder estimate: about $6.7 Mn in 2025, rising to about $106.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Over-the-Counter CGM market in Brazil growing?
Placeholder estimate: about 36.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Over-the-Counter CGM market report cover?
The report splits the market by product (Biosensors, Mobile Apps and Subscriptions), user (Non-Insulin Type 2 Diabetes, Prediabetes, Wellness Users) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Over-the-Counter CGM market?
Key players include Dexcom, Inc., Abbott Laboratories, Levels Health, Nutrisense and Signos.
What is driving the Over-the-Counter CGM market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the over-the-Counter CGM market.
Who regulates Over-the-Counter CGM in Brazil?
Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
What does WHO report for Brazil?
Diabetes (adults): 12.9% of adults in 2022, the latest WHO figure. Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 22 Nov 2026.
How many people in Brazil are 65 or older?
11.5% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 22 Nov 2026.